Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 15 (2) , 99-106
- https://doi.org/10.1038/sj.jhh.1001128
Abstract
Journal of Human Hypertension is exclusively concerned with all clinical aspects of human hypertension. The journal publishes fully refereed original research papers from around the world.Keywords
This publication has 10 references indexed in Scilit:
- Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and MenAnnals of Internal Medicine, 1997
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Renal Insufficiency in Treated Essential HypertensionNew England Journal of Medicine, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.Journal of Clinical Investigation, 1986
- Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidoneThe American Journal of Cardiology, 1985
- MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2The Lancet, 1985
- Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up ProgramArchives of internal medicine (1960), 1985
- Antihypertensive Therapy in Patients Above Age 60 with Systolic HypertensionClinical and Experimental Hypertension. Part A: Theory and Practice, 1982